Literature DB >> 20584460

Endovascular treatment of brain arteriovenous malformations: the toronto experience.

P Klurfan1, T Gunnarsson, C Haw, K G Ter Brugge.   

Abstract

Entities:  

Year:  2005        PMID: 20584460      PMCID: PMC3404767          DOI: 10.1177/15910199050110S109

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


× No keyword cloud information.
  8 in total

1.  N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

Review 2.  Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period.

Authors:  R T Frizzel; W S Fisher
Journal:  Neurosurgery       Date:  1995-12       Impact factor: 4.654

3.  The endovascular treatment of brain arteriovenous malformations.

Authors:  A Valavanis; M G Yaşargil
Journal:  Adv Tech Stand Neurosurg       Date:  1998

4.  Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM.

Authors:  H J Meisel; U Mansmann; H Alvarez; G Rodesch; M Brock; P Lasjaunias
Journal:  Acta Neurochir (Wien)       Date:  2002-09       Impact factor: 2.216

5.  Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate.

Authors:  G M Debrun; V Aletich; J I Ausman; F Charbel; M Dujovny
Journal:  Neurosurgery       Date:  1997-01       Impact factor: 4.654

6.  Embolisation of Small (< 3 cm) Brain Arteriovenous Malformations. Correlation of Angiographic Results to a Proposed Angioarchitecture Grading System.

Authors:  R Willinsky; M Goyal; K Terbrugge; W Montanera; M C Wallace; M Tymianski
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

7.  Risk of endovascular treatment of brain arteriovenous malformations.

Authors:  A Hartmann; J Pile-Spellman; C Stapf; R R Sciacca; A Faulstich; J P Mohr; H C Schumacher; H Mast
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

8.  Complications of preoperative embolization of cerebral arteriovenous malformations.

Authors:  Christopher L Taylor; Kim Dutton; George Rappard; G Lee Pride; Robert Replogle; Phillip D Purdy; Jonathan White; Cole Giller; Thomas A Kopitnik; Duke S Samson
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

  8 in total
  5 in total

1.  Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO).

Authors:  L Pierot; C Cognard; D Herbreteau; H Fransen; W J van Rooij; E Boccardi; A Beltramello; N Sourour; K Kupcs; A Biondi; A Bonafé; W Reith; A Casasco
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

2.  Targeted Embolization of Aneurysms Associated With Brain Arteriovenous Malformations at High Risk for Surgical Resection: A Case-Control Study.

Authors:  Matthew D Alexander; Daniel S Hippe; Daniel L Cooke; Danial K Hallam; Steven W Hetts; Helen Kim; Michael T Lawton; Laligam N Sekhar; Louis J Kim; Basavaraj V Ghodke
Journal:  Neurosurgery       Date:  2018-03-01       Impact factor: 4.654

3.  Less can be more: Targeted embolization of aneurysms associated with arteriovenous malformations unsuitable for surgical resection.

Authors:  Matthew D Alexander; Daniel L Cooke; Danial K Hallam; Helen Kim; Steven W Hetts; Basavaraj V Ghodke
Journal:  Interv Neuroradiol       Date:  2016-04-11       Impact factor: 1.610

4.  Endovascular and microsurgical treatment of cerebral arteriovenous malformations: Current recommendations.

Authors:  Andrew Conger; Charles Kulwin; Michael T Lawton; Aaron A Cohen-Gadol
Journal:  Surg Neurol Int       Date:  2015-03-19

5.  Direct N-butyl-2-cyanoacrylate injections to the head and neck for percutaneous embolized devascularization.

Authors:  Brian Fiani; Marisol Soula; Kasra Sarhadi; Daniel Nikolaidis; Neha Gautam; Nicholas J Fiani; Ryne Jenkins; Alexander Rose
Journal:  Surg Neurol Int       Date:  2021-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.